Introducing Twelve Converter! Real-time currency rates at your fingertips. Available on Android, iOS soon!

ALNY

329.76999 USD
7.71
2.39%
Last update Jul 2, 3:59 PM EDT
Market closed
Day range
319.39999
330
Previous close
322.059998
Open
319.62000
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
329.77
7.71
2.39%

Financials

Income statement

Fiscal date Mar 2025 Dec 2024 Sep 2024 Jun 2024
Total reported revenue 594.2M 593.2M 500.9M 659.8M
Cost of revenue 71.0M 102.8M 85.9M 68.7M
Gross profit 523.1M 490.3M 415.0M 591.2M
Operating expense
Research & development 265.1M 300.2M 270.9M 294.1M
Selling general and admin 239.9M 295.3M 221.0M 248.4M
Other operating expenses
Operating income 18.1M -105.2M -76.9M 48.6M
Non operating interest income
Income 28.7M 31.0M 32.1M 29.2M
Expense 38.6M 39.0M 34.4M 33.3M
Other income expense -49.7M -80.8M -29.5M -55.7M
Pretax income -41.6M -194.0M -108.7M -11.2M
Tax provision 15.9M -110.2M 2.9M 5.7M
Net income -57.5M -83.8M -111.6M -16.9M
Basic EPS -0.4 -0.9 -0.1
Diluted EPS -0.4 -0.9 -0.1
Basic average shares 129.7M 128.6M 126.7M
Diluted average shares 129.7M 128.6M 126.7M
EBITDA 71.3M -84.6M -9.4M 115.8M
Net income from continuing op. -57.5M -83.8M -111.6M -16.9M
Minority interests
Preferred stock dividends
Market closed

Exchange is currently closed
Pre-market opens in 4 days 6 hours 5 minutes

21:54
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).